Enhanced absorption and growth inhibition with amino acid monoester prodrugs of floxuridine by targeting hPEPT1 transporters (Q46417127)

2 July 2019

title

Enhanced absorption and growth inhibition with amino acid monoester prodrugs of floxuridine by targeting hPEPT1 transporters (English)

1 reference

2 July 2019

1 reference

Christopher P. Landowski

4

1 reference

PubMed publication ID

18719516

22 December 2017

http://europepmc.org/abstract/MED/18719516

author name string

Yasuhiro Tsume

1

1 reference

2 July 2019

Balvinder S Vig

2

1 reference

2 July 2019

Jing Sun

3

1 reference

2 July 2019

John M Hilfinger

5

1 reference

2 July 2019

Chandrasekharan Ramachandran

6

1 reference

2 July 2019

Gordon L Amidon

7

1 reference

2 July 2019

language of work or name

English

0 references

publication date

28 June 2008

1 reference

2 July 2019

published in

Molecules

1 reference

2 July 2019

volume

13

1 reference

2 July 2019

issue

7

1 reference

2 July 2019

page(s)

1441-1454

1 reference

2 July 2019

Creative Commons Attribution 4.0 International

copyright license

start time

28 June 2008

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Fluorinated pyrimidines, a new class of tumour-inhibitory compounds

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES13071441

5-Fluorouracil: forty-plus and still ticking. A review of its preclinical and clinical development

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES13071441

Metabolism and mechanism of action of 5-fluorouracil

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES13071441

Comparison of 5-fluoro-2'-deoxyuridine with 5-fluorouracil and their role in the treatment of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES13071441

In vitro and in vivo evaluation of novel antitumor prodrugs of 5-fluoro-2'-deoxyuridine activated by hypoxic irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES13071441

In vitro study on intrathecal use of 5-fluoro-2'-deoxyuridine (FdUrd) for meningeal dissemination of malignant brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES13071441

STUDIES OF FLUORINATED PYRIMIDINES. XVIII. THE DEGRADATION OF 5-FLUORO-2'-DEOXYURIDINE AND RELATED COMPOUNDS BY NUCLEOSIDE PHOSPHORYLASE.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES13071441

Identification of a human valacyclovirase: biphenyl hydrolase-like protein as valacyclovir hydrolase

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES13071441

A novel nucleoside prodrug-activating enzyme: substrate specificity of biphenyl hydrolase-like protein

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES13071441

Nucleoside ester prodrug substrate specificity of liver carboxylesterase

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES13071441

Targeted delivery to PEPT1-overexpressing cells: acidic, basic, and secondary floxuridine amino acid ester prodrugs

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES13071441

Pharmacokinetics of novel dipeptide ester prodrugs of acyclovir after oral administration: intestinal absorption and liver metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES13071441

Interactions of the dipeptide ester prodrugs of acyclovir with the intestinal oligopeptide transporter: competitive inhibition of glycylsarcosine transport in human intestinal cell line-Caco-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES13071441

Modified amino acids and peptides as substrates for the intestinal peptide transporter PepT1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES13071441

Stereoselective uptake of beta-lactam antibiotics by the intestinal peptide transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES13071441

Dipeptide model prodrugs for the intestinal oligopeptide transporter. Affinity for and transport via hPepT1 in the human intestinal Caco-2 cell line.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES13071441

5'-Amino acid esters of antiviral nucleosides, acyclovir, and AZT are absorbed by the intestinal PEPT1 peptide transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES13071441

Pharmacokinetics of the acyclovir pro-drug valaciclovir after escalating single- and multiple-dose administration to normal volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES13071441

Synthesis of analogs of L-valacyclovir and determination of their substrate activity for the oligopeptide transporter in Caco-2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES13071441

Gene Expression in the Human Intestine and Correlation with Oral Valacyclovir Pharmacokinetic Parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES13071441

Intra- and interindividual variabilities of valacyclovir oral bioavailability and effect of coadministration of an hPEPT1 inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES13071441

Transport of amino acid esters and the amino-acid-based prodrug valganciclovir by the amino acid transporter ATB(0,+).

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES13071441

Current prodrug strategies via membrane transporters/receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES13071441

Valacyclovir: a substrate for the intestinal and renal peptide transporters PEPT1 and PEPT2.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES13071441

hPEPT1 affinity and translocation of selected Gln-Sar and Glu-Sar dipeptide derivatives.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES13071441

Metabolism, uptake, and transepithelial transport of the diastereomers of Val-Val in the human intestinal cell line, Caco-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES13071441

Phe-Gly dipeptidomimetics designed for the di-/tripeptide transporters PEPT1 and PEPT2: synthesis and biological investigations.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES13071441

Floxuridine amino acid ester prodrugs: enhancing Caco-2 permeability and resistance to glycosidic bond metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES13071441

Amino acid ester prodrugs of 2-bromo-5,6-dichloro-1-(beta-D-ribofuranosyl)benzimidazole enhance metabolic stability in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES13071441

Amino acid ester prodrugs of the antiviral agent 2-bromo-5,6-dichloro-1-(beta-D-ribofuranosyl)benzimidazole as potential substrates of hPEPT1 transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES13071441

Amino acid ester prodrugs of floxuridine: synthesis and effects of structure, stereochemistry, and site of esterification on the rate of hydrolysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES13071441

Kinetics and substrate specificity of membrane-reconstituted peptide transporter DtpT of Lactococcus lactis

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES13071441

Use of the peptide carrier system to improve the intestinal absorption of L-alpha-methyldopa: carrier kinetics, intestinal permeabilities, and in vitro hydrolysis of dipeptidyl derivatives of L-alpha-methyldopa

21 January 2018

1 reference

12 December 2020

Transport characteristics of differently charged cephalosporin antibiotics in oocytes expressing the cloned intestinal peptide transporter PepT1 and in human intestinal Caco-2 cells

1 reference

12 December 2020

Determinants of substrate affinity for the oligopeptide/H+ symporter in the renal brush border membrane

1 reference

12 December 2020

Cellular uptake mechanism of amino acid ester prodrugs in Caco-2/hPEPT1 cells overexpressing a human peptide transporter

1 reference

12 December 2020

Interactions of a nonpeptidic drug, valacyclovir, with the human intestinal peptide transporter (hPEPT1) expressed in a mammalian cell line

1 reference

12 December 2020

Structure-affinity relationships of Val-Val and Val-Val-Val stereoisomers with the apical oligopeptide transporter in human intestinal Caco-2 cells

1 reference

12 December 2020

Transepithelial transport of the bioactive tripeptide, Val-Pro-Pro, in human intestinal Caco-2 cell monolayers

1 reference

12 December 2020

Evidence for overlapping substrate specificity between large neutral amino acid (LNAA) and dipeptide (hPEPT1) transporters for PD 158473, an NMDA antagonist

1 reference

12 December 2020

Cytotoxic mechanisms of 5-fluoropyrimidines. Relationships with poly(ADP-ribose) polymerase activity, DNA strand breakage and incorporation into nucleic acids

1 reference

12 December 2020

Basis for natural variation in sensitivity to 5-fluorouracil in mouse and human cells in culture.

1 reference

12 December 2020

An oligopeptide transporter is expressed at high levels in the pancreatic carcinoma cell lines AsPc-1 and Capan-2.

1 reference

12 December 2020

Cancer cell-targeted drug delivery utilizing oligopeptide transport activity.

1 reference

12 December 2020

10.3390/MOLECULES13071441

Identifiers

DOI

1 reference

2 July 2019

PMC publication ID

6244841

1 reference

2 July 2019

PubMed publication ID

18719516

1 reference

2 July 2019